Taiho Oncology, Inc.
Michael Schick has over two decades of experience in the pharmaceutical industry. Michael began their career at Bristol-Myers Squibb in 1997, where they served as the Director of Oncology Marketing for seven years. In 2004, they joined Pharmacyclics as the Senior Director of Oncology Marketing. Michael then moved to Amgen in 2006, where they held the position of Executive Director of Global Oncology Marketing. In 2007, they became the Associate Vice President of Marketing at ImClone Systems, a subsidiary of Eli Lilly and Company. From 2009 to 2012, they worked at ALLOS THERAPEUTICS LTD as the Vice President of Sales and Marketing. Currently, they are the Senior Vice President and Chief Commercial Officer at Taiho Oncology, Inc., a position they have held since 2013.
Michael Schick attended Cherokee High School from an unknown start year until 1985. After completing high school, they went on to study at Villanova University from 1985 until 1989. No specific degree or field of study is mentioned for either educational institution.
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com